Article
Efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter randomized Phase II non-inferiority clinical trial
Fecha
2020Registro en:
MOLINA-MORANT, D et al. Efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter randomized Phase II non-inferiority clinical trial. Trials, v. 21, 328, 2020. doi.org/10.1186/s13063-020-4226-2
1745-6215
10.1186/s13063-020-4226-2
Autor
Molina, D.
Fernández, M. L.
Bosch-Nicolau, P.
Sulleiro, E.
Bangher, M.
Salvador, F.
Sanchez-Montalva, A.
Ribeiro, A. L. P.
Paula, A. M. B. de
Eloi, S.
Oliveira, Rodrigo Correa
Villar, J. C.
Sosa-Estani, S.
Molina, I.